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ABSTRACT
NASA is contemplating to build an outpost on the Moon for prolonged human habitation and research. The lunar surface is covered
by a layer of soil, of which the finest portion is highly reactive dust. Dust samples of respirable sizes were aerodynamically isolated
from two lunar soil samples of different maturities (cosmic exposure ages) collected during the Apollo 16 mission. The lunar dust
samples, T102, or quartz, suspended in normal saline were given to groups of 5 C57 male mice by intrapharyngeal aspiration at 0. 1,
0.3, or 1.0 mg/mouse. Because lunar dust aggregates rapidly in aqueous media, some tests were conducted with dusts suspended in
Survanta/saline (1:1). The mice were euthanized 7 or 30 days later, and their lungs were lavaged to assess the presence of toxicity
biomarkers in bronchioalveolar lavage fluids. The overall results showed that the two lunar dust samples were similar in toxicity, they
were more toxic than T102 , but less toxic than quartz. This preliminary study is a part of the large study to obtain data for setting
exposure limits for astronauts living on the Moon (Fig. 1 and 2).
MATERIALS AND METHODS
Animals:	 C57 male mice (-10 week old), 5 per test group
Materials:
	 Apollo 16 sample 461501 (highland mature regolith; Moon Dust 1)
Apollo 16 Sample 962401 (highland sub-mature regolith; Moon dust 2)
Lunar dust simulant (JSC-vfr; an Arizona volcanic ash)
Quartz (Min-U-Sil 5)
T102 (Rutile R-100, a DuPont Product)
Dispersant: saline (Experiment I); Survanta/saline [1:1] (Experiment II)
Procedures:
	 Intrapharyngeal instillation (pharyngeal aspiration)
Bronchloalveolar lavage (BAL) 7d or 30 days after instillation
Assays: LDH activity, total protein concentration, total cell-counts,
cell deferential, and cytokines in BAL fluids.
RESULTS AND CONCLUSION
• Lunar dust particles aggregated rapidly in aqueous media (Fig. 4-6). They
can be satisfactorily suspended in Survanta/saline mixture (Fig. 4, left panel).
• The toxicity of both lunar dust samples is similar (Fig. 7-10).
• Lunar dust suspended in 1:1 Survanta/saline appeared to be more toxic than
that in saline alone in the 7-day study; however, the difference was not
apparent in the 30-day study (Fig. 7-10).
• The overall results show the following relative toxicity:
Saline < Ti02 < lunar dust< lunar dust simulant < quartz.
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Fig. 1. Comparative pulmonary toxicity study of
lunar dust with reference dusts in rats by
intratracheal instillation.
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Fig. 2. Outline of toxicity studies with lunar dusts in
rodents.
Table 1
Treatment Outline of BALF Studies 7 or 30 Days
After the Mice Pharyngeally Aspirated the Test Dusts
Dust Treatment
Dust Dose
Part I
Dust Suspended in
Saline
Part II
Dust Suspended in
SUnTanta/Saline (1:1)
mg/I inouse mg/mouse
Lunar Dust 61501,
(Highland Mature)
High 1.0 1.0
Middle 0.3 0.3
Low 0.1
Lunar Dust 62241,
(Highland Submature)
High 1.0 1.0
Middle 0.3 0.3
0.1
Lunar Dust Simulant
(JSC-vfr)
High 1.0
Middle 0.3
Quartz
Min-U-Sil 5
(positive control)
High 1.0 1.0
Middle 0.3 0.3
Low 0.1
T102
(Negative Control)
High 1.0
Middle 0.3
Low 0.1
Vehicle control Saline Sun, anta + Saline (1:1)
Dusts were suspended in saline (Experiment I) or in 1:1 Savanta/saline (Experiment 11) and intrapharyngeally
instilled in mice. BALF were obtained 7 or 30 days later for toxicity biomarker assessment.
Fig. 3. Particle size of fine respirable dust prepared aerodynamically from
Apollo 16 lunar regolith sample #62401. The dust had a mass median
diameter <2 pm (determined in dry state).
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Fig. 4. Fine lunar dust samples aggregated and precipitated
rapidly (center and right) aqueous media, but can be
satisfactorily suspended in 1:1 Survanta/saline mixture
I	 0 '40`	 (left).
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Fig. 5. The graph shows the particle size distribution of
lunar dust sample #62401 in saline. Some large dust
aggregates had been formed in the freshly-prepared
suspension. The dry dust had a mass median diameter <2
Fig. 6. The graph shows the particle size distribution of
lunar dust in saline determined several hours after the
suspension was prepared; it also shows that the
majority of the particles/aggregates is non-respirable
in size.
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Fig. 7. BALF biomarkers of toxicity were assessed in inice 7 days after pharyngeal aspiration of suspensions of
lunar dust samples and reference dusts (quartz and T10,). The labels for the lunar dust samples and quartz (left to
right) are: high. middle, and low doses in saline; high and middle doses in Survanta.
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Fig. S. BALF biomarkers of toxicity were assessed in mice 30 days after pharyngeal aspiration of suspensions of
lunar dust samples and reference dusts (quartz and TiO ). The labels for the lunar dust samples and quartz (left to
right): high, middle, and low doses in saline; high and middle doses in Survanta.
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Fig. 9. Cytokines in BALF samples were assessed in mice 7 days after pharyngeal aspiration of suspensions of
lunar dust samples and reference dusts (quartz and T102). The labels for the lunar dust samples and quartz (left to
right): high, middle, and low doses in saline-, high and middle doses in Survanta.
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Fig. 10. Cytokines in BALF samples were assessed in mice 7 days after pharyngeal aspiration of suspensions of
lunar dust samples and reference dusts (quartz and T10,). The labels for the lunar dust samples and quartz (left to
right): high, middle, and low doses in saline; high and middle doses in Survanta.
